133 related articles for article (PubMed ID: 37350020)
41. Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.
Dubois S; Viailly PJ; Mareschal S; Bohers E; Bertrand P; Ruminy P; Maingonnat C; Jais JP; Peyrouze P; Figeac M; Molina TJ; Desmots F; Fest T; Haioun C; Lamy T; Copie-Bergman C; Brière J; Petrella T; Canioni D; Fabiani B; Coiffier B; Delarue R; Peyrade F; Bosly A; André M; Ketterer N; Salles G; Tilly H; Leroy K; Jardin F
Clin Cancer Res; 2016 Jun; 22(12):2919-28. PubMed ID: 26819451
[TBL] [Abstract][Full Text] [Related]
42. Diffuse large B-cell lymphomas of immunoblastic type are a major reservoir for MYC-IGH translocations.
Horn H; Staiger AM; Vöhringer M; Hay U; Campo E; Rosenwald A; Ott G; Ott MM
Am J Surg Pathol; 2015 Jan; 39(1):61-6. PubMed ID: 25229766
[TBL] [Abstract][Full Text] [Related]
43. Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma.
Camus V; Sarafan-Vasseur N; Bohers E; Dubois S; Mareschal S; Bertrand P; Viailly PJ; Ruminy P; Maingonnat C; Lemasle E; Stamatoullas A; Picquenot JM; Cornic M; Beaussire L; Bastard C; Frebourg T; Tilly H; Jardin F
Leuk Lymphoma; 2016 Sep; 57(9):2171-9. PubMed ID: 26883583
[TBL] [Abstract][Full Text] [Related]
44. Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma Recurrences.
Berendsen MR; Bladel DAGV; Hesius E; de Groot FA; Kroeze LI; Rijntjes J; Luijks JACW; Hoevenaars B; Halilovic A; Nooijen P; Bladel EV; Jonge-Peeters S; Lensen C; Pruijt H; van der Spek E; Vermaat JSP; Hess C; Hebeda KM; Stevens WBC; van Krieken JHJM; van den Brand M; Groenen PJTA; Scheijen B
Mod Pathol; 2023 May; 36(5):100119. PubMed ID: 36805792
[TBL] [Abstract][Full Text] [Related]
45. Molecular pathology diagnosis of diffuse large B cell lymphoma using BIOMED-2 clonal gene rearrangements.
Ghorbian S
Ann Diagn Pathol; 2017 Aug; 29():28-31. PubMed ID: 28807338
[TBL] [Abstract][Full Text] [Related]
46. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS.
Scheijen B; Meijers RWJ; Rijntjes J; van der Klift MY; Möbs M; Steinhilber J; Reigl T; van den Brand M; Kotrová M; Ritter JM; Catherwood MA; Stamatopoulos K; Brüggemann M; Davi F; Darzentas N; Pott C; Fend F; Hummel M; Langerak AW; Groenen PJTA;
Leukemia; 2019 Sep; 33(9):2227-2240. PubMed ID: 31197258
[TBL] [Abstract][Full Text] [Related]
47. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
Chiu BC; Zhang Z; You Q; Zeng C; Stepniak E; Bracci PM; Yu K; Venkataraman G; Smith SM; He C; Zhang W
Blood Adv; 2019 Oct; 3(19):2790-2799. PubMed ID: 31570490
[TBL] [Abstract][Full Text] [Related]
48. Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy.
Montesinos-Rongen M; Brunn A; Tuchscherer A; Borchmann P; Schorb E; Kasenda B; Altmüller J; Illerhaus G; Ruge MI; Maarouf M; Büttner R; Hansmann ML; Hallek M; Prinz M; Siebert R; Deckert M
J Mol Diagn; 2020 Oct; 22(10):1300-1307. PubMed ID: 32745612
[TBL] [Abstract][Full Text] [Related]
49. PCR-based clonality analysis in diffuse large B-cell lymphoma using BIOMED-2 primers of IgH (FR3) on formalin-fixed paraffin-embedded tissue.
Kosari F; Shishehbor F; Saffar H; Sadeghipour A
Arch Iran Med; 2013 Sep; 16(9):526-9. PubMed ID: 23981156
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population.
Chen W; Wang H; Chen H; Liu S; Lu H; Kong D; Huang X; Kong Q; Lu Z
Eur J Haematol; 2014; 92(5):407-12. PubMed ID: 24400911
[TBL] [Abstract][Full Text] [Related]
51. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
[TBL] [Abstract][Full Text] [Related]
52. Detection of monoclonal immunoglobulin heavy chain gene rearrangement (FR3) in Thai malignant lymphoma by High Resolution Melting curve analysis.
Kummalue T; Chuphrom A; Sukpanichanant S; Pongpruttipan T; Sukpanichanant S
Diagn Pathol; 2010 May; 5():31. PubMed ID: 20482846
[TBL] [Abstract][Full Text] [Related]
53. Mutation Profiling of Malignant Lymphoma by Next-Generation Sequencing of Circulating Cell-Free DNA.
Sun P; Chen C; Xia Y; Wang Y; Liu PP; Bi XW; Shao YW; Ou QX; Wu X; Yang H; Nie M; Zhang XW; Li ZM; Jiang WQ
J Cancer; 2019; 10(2):323-331. PubMed ID: 30719126
[No Abstract] [Full Text] [Related]
54. Simultaneous development of lymphoplasmacytic lymphoma and diffuse large B-cell lymphoma--analyses of the clonal relatedness by sequencing CDR3 in immunoglobulin heavy chain genes.
Shimizu S; Tamagawa Y; Kojima H; Mori N; Nagata M; Noguchi M; Nagasawa T
Eur J Haematol; 2003 Feb; 70(2):119-24. PubMed ID: 12581194
[TBL] [Abstract][Full Text] [Related]
55. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.
Kurtz DM; Green MR; Bratman SV; Scherer F; Liu CL; Kunder CA; Takahashi K; Glover C; Keane C; Kihira S; Visser B; Callahan J; Kong KA; Faham M; Corbelli KS; Miklos D; Advani RH; Levy R; Hicks RJ; Hertzberg M; Ohgami RS; Gandhi MK; Diehn M; Alizadeh AA
Blood; 2015 Jun; 125(24):3679-87. PubMed ID: 25887775
[TBL] [Abstract][Full Text] [Related]
56. Diffuse large B-cell lymphoma: Time to focus on circulating blood nucleic acids?
Regazzo G; Marchesi F; Spagnuolo M; Díaz Méndez AB; Masi S; Mengarelli A; Rizzo MG
Blood Rev; 2021 May; 47():100776. PubMed ID: 33229139
[TBL] [Abstract][Full Text] [Related]
57. [BCL-2/IgH and IgH gene rearrangements in bone marrow mononuclear cells of patients with non-Hodgkin's lymphoma].
Zhang XH; Liang Y; Wang GJ; Ruan EB; Fu R; Qu W; Liu H; Guan J; Song J; Wang HQ; Wu YH; Xing LM; Wang XM; Wang J; Li LJ; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):379-84. PubMed ID: 21518492
[TBL] [Abstract][Full Text] [Related]
58. cfDNA-Based NGS IG Analysis in Lymphoma.
Pott C; Kotrova M; Darzentas N; Brüggemann M; Khouja M;
Methods Mol Biol; 2022; 2453():101-117. PubMed ID: 35622323
[TBL] [Abstract][Full Text] [Related]
59. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.
Hur JY; Kim YJ; Yoon SE; Son DS; Park WY; Kim SJ; Park D; Kim WS
Ann Hematol; 2020 Jun; 99(6):1293-1302. PubMed ID: 32296914
[TBL] [Abstract][Full Text] [Related]
60. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
